PharmEasy, a leading online pharmacy, is preparing to relaunch its initial public offering (IPO) in 2025, two years after withdrawing its previous application. According to the report, the company plans to present its IPO strategy to the board in February, potentially involving a reverse merger with its publicly listed subsidiary, Thyrocare. PharmEasy aims to leverage […]Continue Reading
